Drug Trial Radar · NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
383
Planned (sponsor's estimate)
Start
Dec 21, 2023
Primary completion
Sep 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Clarity Pharmaceuticals LtdIndustry
- Sponsor type
- Industry
- First posted
- Sep 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Conditions
- Prostate Cancer
- Prostatic Neoplasms
Interventions
64Cu-SAR-bisPSMADrug
All Patients will receive a single administration, a bolus injection of 200MBq 64Cu-SAR-bisPSMA.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastasesTime frame: Up to 16 weeks
Locations
34 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama Birmingham Hospital
Birmingham, Alabama · Recruiting
Mayo Clinic- Phoenix
Phoenix, Arizona · Recruiting
Arkansas Urology Research Center, LLC
Little Rock, Arkansas · Recruiting
Urology Group of Southern California
Los Angeles, California · Recruiting
Greater Los Angeles VA Medical Center
Los Angeles, California · Recruiting
UC Irvine Health
Orange, California · Recruiting
Stanford University Medical Center
Stanford, California · Recruiting
Mayo Clinic- Jacksonville
Jacksonville, Florida · Recruiting
Biogenix Molecular, LLC
Miami, Florida · Recruiting
NorthShore University Health System, Glenbrook Hospital
Glenview, Illinois · Recruiting
Indiana University School of Medicine
Indianapolis, Indiana · Recruiting
Wichita Urology Group
Wichita, Kansas · Recruiting
BAMF Health
Grand Rapids, Michigan · Recruiting
Corewell Health
Grand Rapids, Michigan · Recruiting
Mayo Clinic- Rochester
Rochester, Minnesota · Recruiting
XCancer Omaha LLC
Omaha, Nebraska · Recruiting
Albany Medical College, Department of Urology
Albany, New York · Recruiting
Mount Sinai Doctors Urology Faculty Practice
New York, New York · Recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
Urologic Specialists
Tulsa, Oklahoma · Recruiting
Oregon Urology
Springfield, Oregon · Recruiting
Carolina Urologic Research Center
Myrtle Beach, South Carolina · Recruiting
Urology Associates of Nashville
Nashville, Tennessee · Recruiting
Urology Austin, PLLC - Research Department
Austin, Texas · Recruiting
Urology Clinics of North Texas
Dallas, Texas · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
The Urology Place
San Antonio, Texas · Recruiting
Intermountain Health
Murray, Utah · Recruiting
University of Wisconsin
Madison, Wisconsin · Recruiting
St. Vincent's Sydney
Sydney, New South Wales, Australia · Recruiting
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia · Recruiting
Fiona Stanley Hospital
Murdoch, Western Australia, Australia · Recruiting
RAMSAY HEALTH CARE AUSTRALIA PTY LIMITED (ABN 36 003 184 889) trading as Hollywood Private Hospital
Nedlands, Western Australia, Australia · Recruiting
Pan American Center for Oncology Trials, LLC - Ciudadela
San Juan, Puerto Rico · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.